ANRIL: A Long Noncoding RNA in Age-related Diseases

Overview

Journal Mini Rev Med Chem

Publisher Bentham Science Publishers

Specialty Chemistry

Date 2024 May 8

PMID 38716553

Authors

Rui Wang

Qi Yuan

Yuan Wen

Yifan Zhang

Yaqi Hu

Shuwen Wang

Chengfu Yuan

Affiliations

Soon will be listed here.

Abstract

The intensification of the aging population is often accompanied by an increase in agerelated diseases, which impair the quality of life of the elderly. The characteristic feature of aging is progressive physiological decline, which is the largest cause of human pathology and death worldwide. However, natural aging interacts in exceptionally complex ways within and between organs, but its underlying mechanisms are still poorly understood. Long non-coding RNA (lncRNA) is a type of noncoding RNA that exceeds 200 nucleotides in length and does not possess protein-coding ability. It plays a crucial role in the occurrence and development of diseases. ANRIL, also known as CDKN2B-AS1, is an antisense ncRNA located at the INK4 site. It can play a crucial role in agerelated disease progression by regulating single nucleotide polymorphism, histone modifications, or post-transcriptional modifications (such as RNA stability and microRNA), such as cardiovascular disease, diabetes, tumor, arthritis, and osteoporosis. Therefore, a deeper understanding of the molecular mechanisms of lncRNA ANRIL in age-related diseases will help provide new diagnostic and therapeutic targets for clinical practice.

Citing Articles

Association of with Coronary Artery Calcium Differs by Sex and Cigarette Smoking.

Voorhies K, Young K, Hsu F, Palmer N, McDonald M, Lee S J Cardiovasc Dev Dis. 2024; 11(7).

PMID: 39057616 PMC: 11276683. DOI: 10.3390/jcdd11070194.

References

Li Z, Zhang Z, Ren Y, Wang Y, Fang J, Yue H . Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology. 2021; 22(2):165-187. PMC: 7838467. DOI: 10.1007/s10522-021-09910-5. View

Kontis V, Bennett J, Mathers C, Li G, Foreman K, Ezzati M . Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017; 389(10076):1323-1335. PMC: 5387671. DOI: 10.1016/S0140-6736(16)32381-9. View

Niccoli T, Partridge L . Ageing as a risk factor for disease. Curr Biol. 2012; 22(17):R741-52. DOI: 10.1016/j.cub.2012.07.024. View

Zarrouk A, Vejux A, Mackrill J, OCallaghan Y, Hammami M, OBrien N . Involvement of oxysterols in age-related diseases and ageing processes. Ageing Res Rev. 2014; 18:148-62. DOI: 10.1016/j.arr.2014.09.006. View

Hirode G, Wong R . Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016. JAMA. 2020; 323(24):2526-2528. PMC: 7312413. DOI: 10.1001/jama.2020.4501. View

Bao Q, Pan J, Qi H, Wang L, Qian H, Jiang F . Aging and age-related diseases--from endocrine therapy to target therapy. Mol Cell Endocrinol. 2014; 394(1-2):115-8. DOI: 10.1016/j.mce.2014.07.005. View

Dominguez L, Barbagallo M . The biology of the metabolic syndrome and aging. Curr Opin Clin Nutr Metab Care. 2015; 19(1):5-11. DOI: 10.1097/MCO.0000000000000243. View

Arora R, Lee Y, Wischnewski H, Brun C, Schwarz T, Azzalin C . RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nat Commun. 2014; 5:5220. PMC: 4218956. DOI: 10.1038/ncomms6220. View

Delas M, Sabin L, Dolzhenko E, Knott S, Munera Maravilla E, Jackson B . lncRNA requirements for mouse acute myeloid leukemia and normal differentiation. Elife. 2017; 6. PMC: 5619947. DOI: 10.7554/eLife.25607. View

10.

Kitagawa M, Kitagawa K, Kotake Y, Niida H, Ohhata T . Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci. 2013; 70(24):4785-94. PMC: 3830198. DOI: 10.1007/s00018-013-1423-0. View

11.

Matai L, Slack F . MicroRNAs in Age-Related Proteostasis and Stress Responses. Noncoding RNA. 2023; 9(2). PMC: 10143298. DOI: 10.3390/ncrna9020026. View

12.

Wang S, Xiao F, Li J, Fan X, He Z, Yan T . Circular RNAs Involved in the Regulation of the Age-Related Pathways. Int J Mol Sci. 2022; 23(18). PMC: 9500598. DOI: 10.3390/ijms231810443. View

13.

Kleaveland B, Shi C, Stefano J, Bartel D . A Network of Noncoding Regulatory RNAs Acts in the Mammalian Brain. Cell. 2018; 174(2):350-362.e17. PMC: 6559361. DOI: 10.1016/j.cell.2018.05.022. View

14.

Ahn J, Lee H, Lee J, Lee Y, Park J, Kim S . nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer. Nat Commun. 2018; 9(1):1166. PMC: 5862949. DOI: 10.1038/s41467-018-03556-7. View

15.

Jiang L, Shao C, Wu Q, Chen G, Zhou J, Yang B . NEAT1 scaffolds RNA-binding proteins and the Microprocessor to globally enhance pri-miRNA processing. Nat Struct Mol Biol. 2017; 24(10):816-824. PMC: 5766049. DOI: 10.1038/nsmb.3455. View

16.

Zealy R, Fomin M, Davila S, Makowsky D, Thigpen H, Mcdowell C . Long noncoding RNA complementarity and target transcripts abundance. Biochim Biophys Acta Gene Regul Mech. 2018; 1861(3):224-234. PMC: 5924675. DOI: 10.1016/j.bbagrm.2018.02.001. View

17.

Schmidt K, Weidmann C, Hilimire T, Yee E, Hatfield B, Schneekloth Jr J . Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor. Cell Rep. 2020; 30(2):541-554.e5. PMC: 7067293. DOI: 10.1016/j.celrep.2019.12.011. View

18.

Long Y, Wang X, Youmans D, Cech T . How do lncRNAs regulate transcription?. Sci Adv. 2017; 3(9):eaao2110. PMC: 5617379. DOI: 10.1126/sciadv.aao2110. View

19.

Jathar S, Kumar V, Srivastava J, Tripathi V . Technological Developments in lncRNA Biology. Adv Exp Med Biol. 2017; 1008:283-323. DOI: 10.1007/978-981-10-5203-3_10. View

20.

Wang J, Su Z, Lu S, Fu W, Liu Z, Jiang X . LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 2018; 485:229-233. DOI: 10.1016/j.cca.2018.07.004. View